These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 37427852)

  • 21. Prevalence of diabetic retinopathy and diabetic macular edema in a primary care-based teleophthalmology program for American Indians and Alaskan Natives.
    Bursell SE; Fonda SJ; Lewis DG; Horton MB
    PLoS One; 2018; 13(6):e0198551. PubMed ID: 29924846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Cost-Effectiveness Analysis of Intravitreal Aflibercept for the Prevention of Progressive Diabetic Retinopathy.
    Patel NA; Yannuzzi NA; Lin J; Smiddy WE
    Ophthalmol Retina; 2022 Mar; 6(3):213-218. PubMed ID: 34547529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Higher Serum Calcium Level is an Independent Risk Factor for Vision-Threatening Diabetic Retinopathy in Patients with Type 2 Diabetes: Cross-Sectional and Longitudinal Analyses.
    Hu Y; Zhou C; Shi Y; She X; Zhao S; Gu C; Xu X; Chen H; Ma M; Zheng Z
    Endocr Pract; 2021 Aug; 27(8):826-833. PubMed ID: 34000390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy.
    Perais J; Agarwal R; Evans JR; Loveman E; Colquitt JL; Owens D; Hogg RE; Lawrenson JG; Takwoingi Y; Lois N
    Cochrane Database Syst Rev; 2023 Feb; 2(2):CD013775. PubMed ID: 36815723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Prevalence of Diabetic Retinopathy in Australian Adults with Self-Reported Diabetes: The National Eye Health Survey.
    Keel S; Xie J; Foreman J; van Wijngaarden P; Taylor HR; Dirani M
    Ophthalmology; 2017 Jul; 124(7):977-984. PubMed ID: 28318640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term effects of therapy with ranibizumab on diabetic retinopathy severity and baseline risk factors for worsening retinopathy.
    Ip MS; Domalpally A; Sun JK; Ehrlich JS
    Ophthalmology; 2015 Feb; 122(2):367-74. PubMed ID: 25439595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allopurinol and the Risk of Diabetic Macular Edema among U.S. Veterans with Type 2 Diabetes.
    Sutton SS; Magagnoli J; Cummings TH; Hardin JW; Ambati J
    Ocul Immunol Inflamm; 2024 Aug; 32(6):969-975. PubMed ID: 36749950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genome-wide association studies for diabetic macular edema and proliferative diabetic retinopathy.
    Graham PS; Kaidonis G; Abhary S; Gillies MC; Daniell M; Essex RW; Chang JH; Lake SR; Pal B; Jenkins AJ; Hewitt AW; Lamoureux EL; Hykin PG; Petrovsky N; Brown MA; Craig JE; Burdon KP
    BMC Med Genet; 2018 May; 19(1):71. PubMed ID: 29739359
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-mydriatic ultrawide field scanning laser ophthalmoscopy compared with dilated fundal examination for assessment of diabetic retinopathy and diabetic macular oedema in Chinese individuals with diabetes mellitus.
    Szeto SKH; Wong R; Lok J; Tang F; Sun Z; Tso T; Lam TCH; Tham CC; Ng DS; Cheung CY
    Br J Ophthalmol; 2019 Sep; 103(9):1327-1331. PubMed ID: 30381391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diabetic Retinopathy in Patients with Dyslipidemia: Development and Progression.
    Jeng CJ; Hsieh YT; Yang CM; Yang CH; Lin CL; Wang IJ
    Ophthalmol Retina; 2018 Jan; 2(1):38-45. PubMed ID: 31047300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systemic risk factors contribute differently to the development of proliferative diabetic retinopathy and clinically significant macular oedema.
    Bek T
    Diabetologia; 2020 Nov; 63(11):2462-2470. PubMed ID: 32696115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-effectiveness of Intravitreous Ranibizumab Compared With Panretinal Photocoagulation for Proliferative Diabetic Retinopathy: Secondary Analysis From a Diabetic Retinopathy Clinical Research Network Randomized Clinical Trial.
    Hutton DW; Stein JD; Bressler NM; Jampol LM; Browning D; Glassman AR;
    JAMA Ophthalmol; 2017 Jun; 135(6):576-584. PubMed ID: 28492920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors for development and progression of diabetic retinopathy in Dutch patients with type 1 diabetes mellitus.
    Schreur V; van Asten F; Ng H; Weeda J; Groenewoud JMM; Tack CJ; Hoyng CB; de Jong EK; Klaver CCW; Jeroen Klevering B
    Acta Ophthalmol; 2018 Aug; 96(5):459-464. PubMed ID: 30188024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of diabetic retinopathy in individuals with type 2 diabetes who had recorded diabetic retinopathy from retinal photographs in Catalonia (Spain).
    Rodriguez-Poncelas A; Miravet-Jiménez S; Casellas A; Barrot-De La Puente JF; Franch-Nadal J; López-Simarro F; Mata-Cases M; Mundet-Tudurí X
    Br J Ophthalmol; 2015 Dec; 99(12):1628-33. PubMed ID: 26089211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in choroidal thickness in relation to the severity of retinopathy and macular edema in type 2 diabetic patients.
    Kim JT; Lee DH; Joe SG; Kim JG; Yoon YH
    Invest Ophthalmol Vis Sci; 2013 May; 54(5):3378-84. PubMed ID: 23611988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The association between chronic kidney disease and diabetic retinopathy: the Korea National Health and Nutrition Examination Survey 2008-2010.
    Park YH; Shin JA; Han JH; Park YM; Yim HW
    PLoS One; 2015; 10(4):e0125338. PubMed ID: 25849364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of Handheld Retinal Imaging with ETDRS 7-Standard Field Photography for Diabetic Retinopathy and Diabetic Macular Edema.
    Salongcay RP; Aquino LAC; Salva CMG; Saunar AV; Alog GP; Sun JK; Peto T; Silva PS
    Ophthalmol Retina; 2022 Jul; 6(7):548-556. PubMed ID: 35278726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Effect of Delay in Care among Patients Requiring Intravitreal Injections.
    Song W; Singh RP; Rachitskaya AV
    Ophthalmol Retina; 2021 Oct; 5(10):975-980. PubMed ID: 33395587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Racial, Ethnic, and Insurance-Based Disparities Upon Initiation of Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema in the US.
    Malhotra NA; Greenlee TE; Iyer AI; Conti TF; Chen AX; Singh RP
    Ophthalmology; 2021 Oct; 128(10):1438-1447. PubMed ID: 33716048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence and predictors of developing vision-threatening diabetic retinopathy within the first three years of type 2 diabetes.
    Yan J; Li B; Chen Y; Gu C; Dai G; Zhang Q; Zheng Z; Luo D; Zhao S; Zhou C
    Front Endocrinol (Lausanne); 2023; 14():1305378. PubMed ID: 38192422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.